Related by context. Frequent words. (Click for all words.) 64 phase IIa 62 placebo controlled clinical 62 Desmoteplase 61 phase IIb clinical 61 DP b# 61 prospective multicenter 59 phase IIb 59 thrombolytic therapy 59 ELND# 58 Phase Ib clinical 58 Phase 2a trial 58 Thrombolysis 58 GSK# [001] 58 bicifadine 58 TRITON TIMI 58 Phase IIb clinical 58 Viprinex 58 multicenter clinical 58 AZOR 58 double blinded placebo 57 RRMS patients 57 ICA # 57 senicapoc 57 PROPEL trial 57 PFO closure 57 Pivotal Phase III 56 Phase 1b clinical 56 Asentar 56 unblinding 56 IIa trial 56 NLX P# 56 Phase IIb 56 darapladib 56 Phase 2a clinical 56 Phenoptin 56 efficacy endpoint 56 Mipomersen 56 phase 2a 56 muraglitazar 56 alvimopan 55 cardiac dysfunction 55 elotuzumab 55 Phase IIa clinical 55 interferon beta 1b 55 cerebrovascular events 55 alteplase 55 subanalysis 55 placebo controlled randomized 55 ischemic cardiomyopathy 54 carotid artery stenting 54 Cardiac Resynchronization Therapy 54 irbesartan 54 composite endpoint 54 placebo controlled Phase 54 noninferiority 54 Gabapentin GR 54 Phase IIa trial 54 tesmilifene 54 Lu AA# 54 Randomized controlled 54 RSD# 54 Phase 1b trial 54 pharmacodynamic effects 54 KRN# 54 registrational 54 Phase III pivotal 54 unblinded 54 Phase 2b study 54 metastatic hormone refractory 54 olmesartan 54 coronary revascularization 54 confirmatory Phase III 54 GVAX 54 Cloretazine R VNP#M 54 acute ischemic stroke 54 active comparator 54 subgroup analyzes 53 clinical trial 53 deforolimus 53 thromboembolic 53 Bicifadine 53 SPIRIT IV 53 pertuzumab 53 ocrelizumab 53 cardiovascular hospitalization 53 lipid lowering therapy 53 custirsen 53 ATL# [001] 53 omecamtiv mecarbil 53 NVA# 53 Acute Myocardial Infarction 53 tezampanel 53 Phase Ia 53 EVIZON 53 Stedivaze 53 Urocidin 53 ALLHAT 53 axitinib 53 blinded placebo controlled 53 PRX # 53 Pirfenidone